Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CCNL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LTB4R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCAS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR86-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MST1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM198 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C10orf12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMAD6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDH24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRD9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF40 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF397 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALMS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM53C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXN3-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM184A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on